Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/22/2003US6551829 Drying-resistant, practical baker's yeast
04/22/2003US6551828 Compositions and methods for generating expression vectors through site-specific recombination
04/22/2003US6551827 Methods for producing and transforming cassave protoplasts
04/22/2003US6551826 Antisense modulation of raidd expression
04/22/2003US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318
04/22/2003US6551823 EBV-infected stomach cancer cell line
04/22/2003US6551822 NL4 tie ligand homologue
04/22/2003US6551820 Transgenic plants capable of expressing immunogenic polypeptides, including hepatitis B antigen (HBsAg) in quantities sufficient to elicit an immune response in a human or animal that consumes all or a part of the plant
04/22/2003US6551814 Functional, cell-free pyruvate formate lyase obtained from a toluene-degrading bacterium and a functional, cell-free pyruvate formate lyase activating enzyme of a toluene-degrading bacterium
04/22/2003US6551813 Nutrient medium for bacterial strains which overproduce riboflavin
04/22/2003US6551812 Diagnosing PPAR pathophysiologies, and identifying agents for treating these pathophysiologies, using nucleic acids whose expression changes following addition to cells of a ligand for PPAR
04/22/2003US6551811 Protein comprises at least one site for N-linked glycosylation and is attached to a plasma membrane by a glycosylphosphatidylinositol radical
04/22/2003US6551810 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase
04/22/2003US6551808 Desaturase antigen of Mycobacterium tuberculosis
04/22/2003US6551807 Producing a ketocarotenoid in a host cell, by transfecting with nucleotide sequence for expression of carotenoid ketolase
04/22/2003US6551802 Genetic engineering
04/22/2003US6551801 Process for preparing purified dimer of bone-derived factor
04/22/2003US6551800 Recombinant materials for production of a protein toxic to fire ants
04/22/2003US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects
04/22/2003US6551798 Expression vector for use as tool in gene analysis and engineering
04/22/2003US6551797 Expression system for producing proteins
04/22/2003US6551796 Nucleic acid encoding urate transporter and methods of use thereof
04/22/2003US6551793 Carotenoid-associated proteins CHRC and CHRD isolated from corollas of Cucumis sativus; nucleic acids encoding them
04/22/2003US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
04/22/2003US6551786 Screen assay for selecting protein-protein interaction modulators
04/22/2003US6551785 Determining a subject's susceptibility to or the rapidity of progression of sepsis in a subject by detecting at least one allele of an Interleukin-1 proinflammatory haplotype in a nucleic acid sample which indicates increased susceptibility
04/22/2003US6551783 Using a polymerase chain reaction (PCR) based assay in which amplification of nucleic acid is detected by release of a reporter fluorescent signal which is measured as a nomialized reporter value "deltaRn"
04/22/2003US6551781 Methods of screening for compounds that regulate the level of Nramp
04/22/2003US6551778 Nucleic acid sequences amplifying and detecting the prostate-associated genetic markers RNA
04/22/2003US6551777 Methods for preserving DNA integrity
04/22/2003US6551776 Using an oligonucleotide capable of being specifically hybridized with the ribosomal RNA (rRNA) or with the corresponding gene of the E. coli genomic species; probes
04/22/2003US6551775 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
04/22/2003US6551774 Determining the presence or amount of telomerase within a sample obtained from said patient, and correlating the amount of telomerase with a condition associated with an elevated level of telomerase activity
04/22/2003US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
04/22/2003US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival
04/22/2003US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
04/22/2003US6551592 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody
04/22/2003US6551591 New antibiotics derived from the cultures of Microbispora corallina and the physicochemical characteristics of those compounds; has units of dehydrobutyrine, dehydroalanine, aminovinylcysteine and tryptophan
04/22/2003US6551588 Administering at or around the solid tumor an expressible nucleic acid encoding interleukin-3, and providing a tumor antigen, then treating the tumor with radiotherapy
04/22/2003US6551587 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector.
04/22/2003US6551586 Merozoite surface antigen1 (MSA1); vaccinia virus expression vector which expresses a malaria MSA1 peptide in combination with a signal peptide and anchor peptide in a host animal
04/22/2003US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
04/22/2003CA2253636C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
04/22/2003CA2233319C Microsatellite sequences for canine genotyping
04/22/2003CA2207741C Variants of human papilloma virus antigens
04/22/2003CA2170757C Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
04/22/2003CA2163393C Amplification and detection of mycobacteria nucleic acids
04/22/2003CA2152941C Cytopathic viruses for therapy and prophylaxis of neoplasia
04/22/2003CA2137793C Crystallization of m-csf
04/22/2003CA2102623C Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
04/22/2003CA2098295C G protein-coupled glutamate receptors
04/22/2003CA2096975C Cell stress transcriptional factors
04/22/2003CA2091678C Viral defective vaccine produced by transcomplementing cell line
04/22/2003CA2076386C Identification and expression of insect steroid receptor dna sequence
04/22/2003CA1341427C Variants of immunoglobulin gene superfamily member
04/19/2003CA2408762A1 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
04/18/2003WO2002030457A2 Microbes having an attenuating mutation comprising a transcription terminator
04/18/2003CA2463482A1 Microbes having an attenuating mutation comprising a transcription terminator
04/18/2003CA2404050A1 Mb-1 analogs and uses thereof
04/17/2003WO2003031979A1 Randomly ordered arrays and methods of making and using
04/17/2003WO2003031965A2 Microfluidic extraction method
04/17/2003WO2003031942A1 Reagents and methods useful for detecting diseases of the breast
04/17/2003WO2003031940A2 Structural and cytoskeleton-associated proteins
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
04/17/2003WO2003031937A2 Genetic hypermutability of plants for gene discovery and diagnosis
04/17/2003WO2003031934A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna
04/17/2003WO2003031930A2 A phosphatase associated with metastasis
04/17/2003WO2003031929A2 Devices and methods for detecting genetic sequences
04/17/2003WO2003031653A1 METHOD OF SELECTING BARLEY VARIETY, BARLEY β-AMYLASE GENE AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK
04/17/2003WO2003031650A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
04/17/2003WO2003031645A1 Preincubation assay method using single-stranded nucleic acid oligomer
04/17/2003WO2003031641A2 Beta 2 adrenergic polymorphism detection
04/17/2003WO2003031633A2 Adenoviral vector system
04/17/2003WO2003031632A1 An efficient system for rna silencing
04/17/2003WO2003031631A1 Modification of plant responses to salt
04/17/2003WO2003031630A1 Multi-cistronic vectors for gene transfer protocols
04/17/2003WO2003031629A1 Methods of preparing a targeting vector and uses thereof
04/17/2003WO2003031628A1 Secretory polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
04/17/2003WO2003031627A1 Platelet-origin polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
04/17/2003WO2003031626A1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same
04/17/2003WO2003031625A1 Esterase esta extracted from rhodococcus ruber
04/17/2003WO2003031624A1 Nucleotide sequence that codes for a pseudomonas putida phaf protein
04/17/2003WO2003031623A1 Cocoa flavour precursor peptides
04/17/2003WO2003031622A1 Manipulation of flavonoid biosynthesis in plants
04/17/2003WO2003031621A2 A human g protein coupled receptor
04/17/2003WO2003031620A1 Novel class ii cytokine receptor
04/17/2003WO2003031619A1 Apparatus for collecting nucleic acid and method of collecting nucleic acid
04/17/2003WO2003031618A1 Method of collecting nucleic acid
04/17/2003WO2003031617A1 Method and device for isolating rna samples
04/17/2003WO2003031616A2 Methods for dna mutagenesis and dna-cloning
04/17/2003WO2003031613A2 Regulation of translation of heterologously expressed genes
04/17/2003WO2003031612A2 Method for determining cell cycle position
04/17/2003WO2003031611A2 Phagemid display system
04/17/2003WO2003031609A1 Esterase esta of rhodococcus sp.
04/17/2003WO2003031608A2 Mutated abl kinase domains
04/17/2003WO2003031604A1 Gastrointestinal chemosensory receptors
04/17/2003WO2003031603A1 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
04/17/2003WO2003031602A1 The oncolytic microorganisms expressing hsp and uses thereof
04/17/2003WO2003031600A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel
04/17/2003WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use